CVS Health forward PE CVS
Share price divided by analysts' consensus earnings for the next twelve months, since 1996.
- Today, Oct 23, 2026
- 11.5×
- 10-year median
- 10.9×
- Against its 10-year history
- 66th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 7.7× to 15.3×
- Peer median
- 16.1×
CVS Health's forward PE is 11.5× as of Oct 23, 2026.
That is above its ten-year median of 10.9×, higher than on 66% of days in the last ten years.
Over that time it ranged from 7.7× in May 2019 to 15.3× in Oct 2016.
The median for 5 health insurers of a similar size is 16.1×.
Forward PE over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 11.5× | 10.1× | 14.5× |
| 2025 | 11.9× | 8.4× | 12.9× |
| 2024 | 8.2× | 8.2× | 13.8× |
| 2023 | 11.5× | 8.5× | 11.5× |
| 2022 | 11.3× | 10.8× | 13.3× |
| 2021 | 12.6× | 9.2× | 12.6× |
| 2020 | 10.0× | 8.8× | 11.7× |
| 2019 | 11.4× | 7.7× | 11.5× |
| 2018 | 9.4× | 9.2× | 12.8× |
| 2017 | 11.3× | 11.0× | 15.1× |
| 2016 | 14.5× | 13.6× | 19.3× |
| 2015 | 17.9× | 16.8× | 21.8× |
| 2014 | 20.9× | 15.3× | 20.9× |
| 2013 | 16.5× | 13.3× | 16.5× |
| 2012 | 12.8× | 11.9× | 14.0× |
| 2011 | 13.1× | 11.0× | 13.9× |
| 2010 | 13.4× | 10.6× | 13.8× |
| 2009 | 12.0× | 9.6× | 14.1× |
| 2008 | 10.8× | 10.7× | 18.0× |
| 2007 | 17.4× | 17.0× | 19.7× |
Against its peers
Companies in Medical - Healthcare Plans nearest CVS Health's size, closest first, today.
| Company | Forward PE |
|---|---|
| CVSCVS Health | 11.5× |
| ELVElevance Health | 16.1× |
| CICigna | 9.7× |
| HUMHumana | 33.7× |
| UNHUnitedHealth | 18.5× |
| CNCCentene | 15.0× |
| Peer median | 16.1× |
Where CVS Health ranks
What the forward PE tells you
Price divided by what analysts expect the company to earn over the next twelve months. It answers "what am I paying for next year" instead of last year.
Estimates are opinions. When forward PE is far below trailing PE, analysts expect a big jump in earnings. If that jump slips, the stock was not as cheap as it looked.
More on CVS Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.